Haloperidol

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Haloperidol and local guidelines before prescribing.

Butyrophenone antipsychotic

Mechanism

Butyrophenone antipsychotic blocking dopamine D2 receptors.

Uses

Acute psychosis and agitation, delirium (short term), nausea in palliative care, tics.

Dosing

4 more dose entries from the chapters

Side effects

Extrapyramidal effects, akathisia, QT prolongation, neuroleptic malignant syndrome, hyperprolactinaemia.

Interactions

QT-prolonging drugs, other dopamine antagonists, levodopa antagonism.

Contraindications and cautions

QT prolongation, Parkinson disease, Lewy body dementia, CNS depression

Monitoring

ECG, extrapyramidal signs

Pregnancy and breastfeeding

Avoid unless essential

Renal and hepatic impairment

Reduce dose in liver impairment

Overdose and reversal

Supportive; ECG and electrolytes

Special advice

ECG before use if cardiac risk; avoid in Parkinson disease and Lewy body dementia; lowest dose in older people.

More from the textbook: uses, cautions and other points
Where it is discussed in the book